Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline

Phillip Blanchette; Duvaraga Sivajohanathan; John Bartlett; Andrea Eisen; Harriet Feilotter; Rossanna Pezo; Gulisa Turashvili; Phillip Williams

doi:10.3390/curroncol29040213

Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline

Phillip Blanchette, Duvaraga Sivajohanathan, John Bartlett, Andrea Eisen, Harriet Feilotter, Rossanna Pezo, Gulisa Turashvili, Phillip Williams

School of Population Health Sciences

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	2599-2616
Journal	Current Oncology
Volume	29
Issue number	4
DOIs	https://doi.org/10.3390/curroncol29040213
Publication status	Published - 9 Apr 2022

Access to Document

10.3390/curroncol29040213Licence: CC BY

curroncol-29-00213-v2
Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/4.0/).
Final published version, 970 KBLicence: Creative Commons: Attribution (CC-BY)

https://www.mdpi.com/1718-7729/29/4/213

Cite this

@article{13071abbc90548cca1e41d61ff831b6c,

title = "Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline",

author = "Phillip Blanchette and Duvaraga Sivajohanathan and John Bartlett and Andrea Eisen and Harriet Feilotter and Rossanna Pezo and Gulisa Turashvili and Phillip Williams",

note = "Funding Information: Funding: The PEBC is a provincial initiative of Ontario Health (Cancer Care Ontario) supported by the Ontario Ministry of Health. All work produced by the PEBC is editorially independent of the Ontario Ministry of Health. Publisher Copyright: {\textcopyright} 2022 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2022",

month = apr,

day = "9",

doi = "10.3390/curroncol29040213",

language = "English",

volume = "29",

pages = "2599--2616",

journal = "Current Oncology",

issn = "1718-7729",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "4",

}

TY - JOUR

T1 - Clinical Utility of Multigene Profiling Assays in Early-Stage Invasive Breast Cancer: An Ontario Health (Cancer Care Ontario) Clinical Practice Guideline

AU - Blanchette, Phillip

AU - Sivajohanathan, Duvaraga

AU - Bartlett, John

AU - Eisen, Andrea

AU - Feilotter, Harriet

AU - Pezo, Rossanna

AU - Turashvili, Gulisa

AU - Williams, Phillip

N1 - Funding Information: Funding: The PEBC is a provincial initiative of Ontario Health (Cancer Care Ontario) supported by the Ontario Ministry of Health. All work produced by the PEBC is editorially independent of the Ontario Ministry of Health. Publisher Copyright: © 2022 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2022/4/9

Y1 - 2022/4/9

U2 - 10.3390/curroncol29040213

DO - 10.3390/curroncol29040213

M3 - Article

SN - 1718-7729

VL - 29

SP - 2599

EP - 2616

JO - Current Oncology

JF - Current Oncology

IS - 4

ER -